(Q40365814)
Statements
The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer (English)
Sotaro Miwa
Atsushi Mizokami
Evan T Keller
Jian Zhang
scientific article published on October 2005
No description defined